Johnson Financial Group Inc (Wisconsin)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.85K | Sell |
184
-313
| -63% | -$17K | ﹤0.01% | 649 |
|
|
2026
Q1 | $31.2K | Hold |
497
| – | – | ﹤0.01% | 525 |
|
|
2025
Q4 | $47.4K | Sell |
497
-238
| -32% | -$23.3K | ﹤0.01% | 512 |
|
|
2025
Q3 | $71.8K | Buy |
735
+487
| +196% | +$50.4K | ﹤0.01% | 525 |
|
|
2025
Q2 | $26.6K | Sell |
248
-567
| -70% | -$57.4K | ﹤0.01% | 514 |
|
|
2025
Q1 | $82.2K | Buy |
815
+346
| +74% | +$34.8K | ﹤0.01% | 524 |
|
|
2024
Q4 | $48K | Buy |
469
+176
| +60% | +$15.5K | ﹤0.01% | 501 |
|
|
2024
Q3 | $24.6K | Buy |
293
+247
| +537% | +$19.5K | ﹤0.01% | 588 |
|
|
2024
Q2 | $3.54K | Buy |
+46
| New | +$3.37K | ﹤0.01% | 639 |
|
|
2024
Q1 | – | Sell |
-555
| Closed | -$32.1K | – | 802 |
|
|
2023
Q4 | $32.1K | Sell |
555
-124
| -18% | -$6.62K | ﹤0.01% | 498 |
|
|
2023
Q3 | $35.9K | Buy |
679
+139
| +26% | +$7.29K | ﹤0.01% | 430 |
|
|
2023
Q2 | $29.2K | Sell |
540
-58
| -10% | -$3.03K | ﹤0.01% | 459 |
|
|
2023
Q1 | $29.9K | Buy |
598
+167
| +39% | +$7.87K | ﹤0.01% | 446 |
|
|
2022
Q4 | $19.9K | Buy |
+431
| New | +$18.7K | ﹤0.01% | 438 |
|
|
2022
Q1 | – | Sell |
-394
| Closed | -$17K | – | 689 |
|
|
2021
Q4 | $17K | Buy |
+394
| New | +$16.6K | ﹤0.01% | 578 |
|
|
2019
Q4 | – | Sell |
-582
| Closed | -$24K | – | 523 |
|
|
2019
Q3 | $24K | Sell |
582
-105
| -15% | -$4.45K | ﹤0.01% | 389 |
|
|
2019
Q2 | $30K | Hold |
687
| – | – | ﹤0.01% | 371 |
|
|
2019
Q1 | $26K | Hold |
687
| – | – | ﹤0.01% | 368 |
|
|
2018
Q4 | $24K | Hold |
687
| – | – | ﹤0.01% | 370 |
|
|
2018
Q3 | $26K | Hold |
687
| – | – | ﹤0.01% | 380 |
|
|
2018
Q2 | $22K | Hold |
687
| – | – | ﹤0.01% | 393 |
|
|
2018
Q1 | $19K | Hold |
687
| – | – | ﹤0.01% | 417 |
|
|
2017
Q4 | $17K | Hold |
687
| – | – | ﹤0.01% | 446 |
|
|
2017
Q3 | $20K | Buy |
687
+504
| +275% | +$13.9K | ﹤0.01% | 418 |
|
|
2017
Q2 | $5K | Buy |
+183
| New | +$4.86K | ﹤0.01% | 500 |
|
|
2017
Q1 | – | Sell |
-583
| Closed | -$13K | – | 653 |
|
|
2016
Q4 | $13K | Hold |
583
| – | – | ﹤0.01% | 561 |
|
|
2016
Q3 | $14K | Hold |
583
| – | – | ﹤0.01% | 550 |
|
|
2016
Q2 | $14K | Hold |
583
| – | – | ﹤0.01% | 636 |
|
|
2016
Q1 | $11K | Hold |
583
| – | – | ﹤0.01% | 597 |
|
|
2015
Q4 | $11K | Buy |
583
+440
| +308% | +$7.88K | ﹤0.01% | 624 |
|
|
2015
Q3 | $2K | Hold |
143
| – | – | ﹤0.01% | 756 |
|
|
2015
Q2 | $3K | Buy |
+143
| New | +$2.56K | ﹤0.01% | 789 |
|
Other funds holding BSX
Johnson Financial Group Inc (Wisconsin)'s BSX Position: Q2 2026 in Review
Johnson Financial Group Inc (Wisconsin) reduced its Boston Scientific (BSX) stake by 63% in Q2 2026, selling an estimated $17K and leaving 184 shares worth $7.85K. The position accounts for ﹤0.01% of the portfolio, ranked #649.
Johnson Financial Group Inc (Wisconsin) first reported a position in BSX in Q2 2015 and has held it in 32 quarters since. The position peaked at $82.2K in Q1 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Johnson Financial Group Inc (Wisconsin) held 184 shares of Boston Scientific worth $7.85K as of Q2 2026.
- Johnson Financial Group Inc (Wisconsin) sold 313 Boston Scientific shares in Q2 2026, an estimated $17K.
- Boston Scientific made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #649 holding.
- Johnson Financial Group Inc (Wisconsin) first reported a position in Boston Scientific in Q2 2015 and has held it in 32 quarters since.
- Johnson Financial Group Inc (Wisconsin)'s Boston Scientific position peaked at $82.2K in Q1 2025.
- 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.